Is the Japara Healthcare Ltd (ASX:JHC) share price a buy?

The Japara Healthcare Ltd (ASX:JHC) share price looks interesting.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Japara Healthcare Ltd (ASX: JHC) share price is at the lowest it has been in 2018. It's worth considering if it is a buy today.

It's one of the largest aged care providers in Australia and has pleasing tailwinds due to the ageing demographics of Australia.

The company recently acquired Riviera Health, which included four operating aged care facilities at Chatswood, Doonside, Brighton-Le-Sands and Wyong, a near completed replacement facility at Brighton-Le-Sands, 239 surplus bed licenses and other real estate assets.

Since the acquisition, Japara has implemented its operating standards in all the operating homes, as well reconfiguring the homes by converting multiple bed wards into single rooms.

Japara has also received full re-accreditation at the Wyong and Doonside homes after the Department of Health had previously sanctioned the previous owner. Japara met all 44 of the Australian Aged Care Quality Agency expected outcomes.

The Japara CEO, Me Andrew Sudholz was pleased with how quickly Japara received accreditation considering the short amount of time the company owned the new locations.

This purchase enables Japara to start a portfolio of 'premium' newly built aged care homes in Sydney.

Me Sudholz said that the acquisition for $39 million was exceptional value because Japara purchased four operating homes for little cost due to the expected cash receipts from the refundable accommodation deposits at the new Brighton-Le-Sands home, the value of the surplus licenses and the other real estate acquired.

The four Riviera Health operating homes are expected to provide an operating earnings before interest, tax depreciation and amortisation (EBITDA) uplift of between $3.5 million to $4 million.

Foolish takeaway

Japara is currently trading at around 17x FY17's earnings. Japara is a tough one to judge because of how dependent it is on a supportive government. However, it does appear good value for how earnings will come online over the next three years.

Motley Fool contributor Tristan Harrison owns shares of JAPARA DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »